Market analysis report for viral inactivation 2025-2030:

Dublin, February 25, 2025 (Globe Newswire) – The report “Viral Inactivation Market Size, Share & Trends Analysis” by Product & Service (Kits & Reatzs) according to application (vaccine & therapeutic agent) after end consumption by region and segment forecast, 2025 – 2030 “Was added Researchandmarkets.com Offer.

The global market size for viral inactivation size reaches USD 1.37 billion by 2030 and registers a CAGR of 11.58% from 2025 to 2030

The number of pharmaceutical and biopharmaceutical companies, the increase in the approvals of FDA drugs, the growth of the biosciences, the increase in state financing of new therapies and the development of medicinal products are some of the most important factors that contribute to growth.

In the pharmaceutical and biopharmaceutical industry, immense growth with a steady increase in the number of companies, the medication start and the new drug discoveries was observed. With an increase in the number of diseases worldwide, the need for new and improved drugs and therapies was observed on the global front. The increase in investments by top actors in research and development in connection with the need to find new therapies for the treatment of diseases has contributed to the immense growth of pharmaceutical and biopharmaceutical companies, which accelerates growth.

New drugs are developed by companies to offer incremental health benefits. Changed lifestyle of people around the world and the introduction of seating habits are the main reasons for the increase in the number of chronic diseases that require medication and therapies for treatment. According to the FDA, 41 new drugs were approved in 2014 and 45 in the following year. This also contributed to the growth.

In the past few years, immense funds have been observed in the pharmaceutical and biotechnology industry. It has been observed that private actors are the most important participants for the development of new medication and therapies. However, state expenditure on research and development of new therapies has been increased. The increase in financing has also led to growth in the number of FDA registrations in recent years. All of these factors have contributed to the immense growth of the viral inactivation market.

The market report for viral inactivation brand Highlights

• The product segment of KITS & RAGENTENTEN led the market with the largest share of sales of 57.37% in 2024, which was due to the increase in biopharmaceutical and biotechnological companies worldwide.
• After application, the segment of vaccines and therapeutic agents in 2024 was the largest share of sales of 34.41%, which was due to the increasing investments in f&E applications such as gene therapy and stem cell research.
• In 2024, the Pharmaceutical and Biotechnology Companies segment headed the market with the largest share of sales of 38.51%, which was due to the growth of pharmaceutical and biopharmaceutical companies.
• Due to the presence of the dominant actors and the availability of sophisticated infrastructure together with the reforms of the healthcare system, the largest proportion of the dominant actors and the availability of sophisticated infrastructure accounts for.

Companies presented

• Charles River Laboratories, Inc.
• Clean cells
• Cytiva (Danaher Corporation)
• Merck KGAA
• Mettler Toledo
• Parker Hannifin Corp
• Rad Source Technologies Inc.
• Sartorius AG
• Texcell SA
• Vironova off

Key attributes:

Covered topics covered:

Chapter 1. Methodology and scope

Chapter 2. Executive summary
2.1. Market outlook
2.2. Segment snapshot
2.3. Competition landscape snapshot

Chapter 3. Viral inactivation variables, trends and scope
3.1. Market line view
3.1.1. Parents' market outlook
3.1.2. Related/side market laughter
3.2. Market dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for biopharmaceuticals
3.2.1.2. Technological progress in viral inactivation
3.2.2. Market restriction analysis
3.2.2.1. High costs for viral inactivation techniques
3.3. Industry analysis tools
3.3.1. Porters five forces analyzes
3.3.2. Pestel analysis
3.3.3. COVID-19-exhaustion analysis

Chapter 4. Market for Viral Inactivation: Product and Service Estimates and Trend Analysis
4.1. Product and service segment -Dashboard
4.2. Global market for viral inactivation market product & service movement analysis
4.3. Global market size and trend analysis of viral inactivation, from Product & Service, 2018 to 2030 (million USD)
4.4. Kits & reagents
4.4.1. Kits & reagentzent market sales estimates and forecasts, 2018 – 2030 (million USD)
4.5. Systems and accessories
4.6. Services

Chapter 5. Market for Viral Inactivation: Applications and Trend Analysis
5.1. Application segment dashboard
5.2. Global market analysis of the viral inactivation market application movement
5.3. Global market size and trend analysis of viral inactivation, after application, 2018 to 2030 (million USD)
5.4. Vaccines and therapeutic agents
5.5. Stem cell products
5.6. Blood and blood products
5.7. Tissue/ tissue products
5.8. Cell and gene therapy

Chapter 6. Market for Viral Inactivation: Estimates of the final use and trend analysis
6.1. End use segment dashboard
6.2. Global market for viral inactivation market End usage movement analysis
6.3. Global market size and trend analysis of viral inactivation, after end consumption, 2018 to 2030 (million $)
6.4. Pharmaceutical and biotechnological companies
6.4.1. Pharmaceutical and biotechnological companies market sales estimates and forecasts, 2018 – 2030 (million USD)
6.5. Crosa
6.6. Academic and research institutes
6.7. Other

Chapter 7. Market for viral inactivation: regional estimates and trend analysis
7.1. Regional market share analysis, 2024 & 2030
7.2. Regional market dashboard
7.3. Market size & forecasts and trend analysis, 2018 to 2030

Chapter 8. Competition landscape
8.1. Participant categorization
8.2. Corporate market position analysis, 2024
8.3. Overview of the participant

More information about this report Visit

Via Research undmarkets.com
Researchandmarkets.com is the world's leading source for international market research reports and market data. We offer you the latest data on international and regional markets, important industries, the best companies, new products and the latest trends.

• Viral inactivation market